About ProteoWise
ProteoWise is a private company based in New Haven, Connecticut. It has reported $11,255,518 raised in three offerings on Form D since March 2020. Its chief executive is Erik Gunther.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 6, 2024 | Dec 13, 2024 | $2,306,020of $10.0M target | 6 | $384K | Equity, OptionsRule 506(b) | Form D ↗ |
| Mar 31, 2021 | Apr 13, 2021 | $2,653,558fully sold | 5 | $530K | EquityRule 506(b) | Form D ↗ |
| Mar 23, 2020 | Mar 27, 2020 | $6,295,940fully sold | 15 | $419K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $11,255,518 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on ProteoWise's Form D filed Dec 13, 2024.
DW
Daniel Wagner
Director
BC
Benjamin Comb
Director
EG
Erik Gunther
Chief Executive Officer and director
DS
David Smoller
Director